Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102827912B reveals a novel two-enzyme one-step method for D-7-ACA production, offering significant cost reduction in antibiotic manufacturing and enhanced supply chain reliability.
Patent CN115433249B details high-yield Rebaudioside L2 synthesis. Offers cost reduction and supply chain reliability for global food additive manufacturing.
Patent CN102876582B details a novel Metarhizium anisopliae strain for efficient 11α-hydroxylation. This biocatalytic route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101760495A details a non-toxic bio-route for steroid 1,2-dehydrogenation using Arthrobacter simplex, ensuring high purity and scalable manufacturing for global supply chains.
Patent CN110656147B reveals a high-yield biological method for steroid intermediates. Reduces costs and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN101760496A details a biological dehydrogenation method for steroid intermediates using Arthrobacter simplex, offering a safer, high-yield alternative to toxic chemical processes for reliable supply chains.
Patent CN112342261B reveals a green route for prednisone acetate using RSA. Discover cost-effective biocatalytic hydroxylation and oxidation for high-purity steroid production.
Patent CN109680032B reveals a high-yield microbial route for steroid hydroxylation. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN110951815A details a novel biocatalytic route for steroid intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN117431292B reveals a high-yield one-step fermentation for 8DM. Discover cost reduction in steroid manufacturing and reliable supply chain solutions.
Patent CN110272839A enables high-purity chiral acid synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN104531794B reveals enzymatic route for high-purity chiral intermediate with scalable production capabilities and cost advantages.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Patent CN1111677A reveals a thermophilic Bacillus smithii strain for stable nitrile hydration, enabling cost reduction in pharmaceutical intermediate manufacturing without cooling.
Discover a robust biocatalytic route for (2S, 3R)-methyl phenyl glycidate using Enterobacter sp. ECU 1107, offering superior purity and scalable manufacturing for taxol synthesis.
Novel ketoreductase method for ezetimibe intermediate. Reduces cost, improves purity. Reliable supplier for pharma intermediates.
Patent CN115948360B reveals high-efficiency biocatalytic route for neurodegenerative drug intermediates with superior stereoselectivity and scalable production potential.
Patent CN101898990B details Rhodococcus erythropolis AJ270 catalyzed hydrolysis for high-purity chiral azetidine intermediates, offering cost-effective scalable manufacturing solutions.
Novel PAMO enzyme technology enables green, one-step synthesis of esomeprazole with >99% ee, eliminating sulfone byproducts and reducing manufacturing costs for pharmaceutical supply chains.
Novel yeast-displayed lipase method for Vitamin E Linoleate production. Achieves higher conversion rates, reduces costs, and ensures scalable supply for pharmaceutical applications.